LOL Another PR in which the Co's fwd statements ar
Post# of 72440
like MONEY is not an issue.
''positioning itself to further advance Brilacidin,MOST IMMEDIATELY,
in it's planned Ph3 OM trial''
''Also in the coming weeks,the Co plans to provide an update on
it's Brilacidin program for the treatment for IBD''
What do they know that we dont?..........yet